share_log

HC Wainwright & Co. Reiterates Buy on Cullinan Oncology, Maintains $49 Price Target

Benzinga ·  Jul 7, 2023 06:05

HC Wainwright & Co. analyst Edward White reiterates Cullinan Oncology (NASDAQ:CGEM) with a Buy and maintains $49 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment